Humanwell Healthcare
Humanwell Healthcare insists on R&D as the guide
Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM